Bellevue Group AG

Q2 2023 13F-HR Detailed Holdings

Location
Kuesnacht, V8
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
198
Total value ($000)
$7,010,439
Net value change ($000)
+119,272 (1.7%)
New positions
9
Sold out positions
12
Turnover %
1.8%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/15/2023 Next filing: 11/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IONS 44,919 13.2%
LLY 40,929 1107.1%
ISRG 40,494 16.4%
MRK 34,636 4599.7%
EVH 33,381 46.9%
BDTX 30,888 302.9%
ARGX 29,379 8.9%
INSP 27,643 31.3%
BMRN 26,546 563.5%
Intra-Cellular Therapies, Inc. 25,776 14.6%
Top Reduces (Value $000, Stocks/ETFs)
SRPT -66,194 -74.3%
MRNA -53,016 -22.2%
JAZZ -47,587 -57.1%
DHR -40,946 -48.2%
INCY -40,895 -19.9%
HCA -31,389 -39.2%
PFE -30,220 -100.0%
HALO -28,352 -100.0%
BSX -28,124 -16.3%
APLS -25,940 -35.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408